{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:15:34Z","timestamp":1764332134456},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,5,5]],"date-time":"2013-05-05T00:00:00Z","timestamp":1367712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00415-013-6938-7","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T07:45:49Z","timestamp":1367653549000},"page":"2052-2056","source":"Crossref","is-referenced-by-count":39,"title":["Immunoglobulin G level variations in treated chronic inflammatory demyelinating polyneuropathy: clues for future treatment regimens?"],"prefix":"10.1007","volume":"260","author":[{"given":"Yusuf A.","family":"Rajabally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,5]]},"reference":[{"key":"6938_CR1","first-page":"002063","volume":"6","author":"RA Hughes","year":"2010","unstructured":"Hughes RA, Swan AV, van Doorn PA (2010) Intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome. Cochrane Database Syst Rev 6:002063","journal-title":"Cochrane Database Syst Rev"},{"key":"6938_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/157015909790031166","volume":"7","author":"S Jacob","year":"2009","unstructured":"Jacob S, Rajabally YA (2009) Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. Current Neuropharmacol 7:337\u2013342","journal-title":"Current Neuropharmacol"},{"key":"6938_CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1529-8027.2006.00105.x","volume":"11","author":"YA Rajabally","year":"2006","unstructured":"Rajabally YA, Seow H, Wilson P (2006) Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 11:325\u2013329","journal-title":"J Peripher Nerv Syst"},{"key":"6938_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.21737","volume":"66","author":"K Kuitwaard","year":"2009","unstructured":"Kuitwaard K, de Gelder J, Tio-Gillen AP et al (2009) Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain\u2013Barr\u00e9 syndrome. Ann Neurol 66:597\u2013603","journal-title":"Ann Neurol"},{"issue":"3","key":"6938_CR5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1529-8027.2011.00304.x","volume":"16","author":"PA Doorn van","year":"2011","unstructured":"van Doorn PA, Kuitwaard K, Jacobs BC (2011) Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP. J Peripher Nerv Syst 16(3):38\u201340","journal-title":"J Peripher Nerv Syst"},{"key":"6938_CR6","doi-asserted-by":"crossref","unstructured":"Kuitwaard K, van Doorn PA, van den Berg LH, et al (2013) Serum IgG levels in immunoglobulin treated chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (Epub ahead of print)","DOI":"10.1136\/jnnp-2012-304670"},{"key":"6938_CR7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Bergh Van den","year":"2010","unstructured":"Van den Bergh PY, Hadden RD, Bouche P et al (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society- First Revision. Eur J Neurol 17:356\u2013363","journal-title":"Eur J Neurol"},{"key":"6938_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","volume":"66","author":"MP Lunn","year":"1999","unstructured":"Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK (1999) Chronic inflammatory demyelinating polyneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66:677\u2013680","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6938_CR9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.21206","volume":"39","author":"YA Rajabally","year":"2009","unstructured":"Rajabally YA, Simpson BS, Beri S, Bankart J, Gosalakal J (2009) Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle Nerve 39:432\u2013438","journal-title":"Muscle Nerve"},{"key":"6938_CR10","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367\u20132375","journal-title":"JAMA"},{"key":"6938_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","volume":"67","author":"SI Nes van","year":"2011","unstructured":"van Nes SI, Vanhoutte EK, van Doorn PA et al (2011) Raasch-built overall disabilty Scale (R-ODS) for immune mediated peripheral neuropathies. Neurology 67:337\u2013345","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6938-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-6938-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6938-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:23:13Z","timestamp":1559071393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-6938-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,5]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["6938"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-6938-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,5]]}}}